Gsk (GSK) Notes Payables (2009 - 2026)
Gsk (GSK) posted quarterly Notes Payables of -$5.8 billion for Q2 2026, down 110.51% year-over-year from $54.8 billion in Q2 2025, and up 15.34% quarter-over-quarter from -$6.8 billion in Q1 2026.
Gsk (GSK) Notes Payables (2009 - 2026) Analysis & Trends
Gsk's Notes Payables history runs 18 years deep, the most recent figure standing at -$5.8 billion for Q2 2026.
- In Q2 2026, Notes Payables fell 110.51% year-over-year to -$5.8 billion; the TTM figure through Jun 2026 stood at -$5.8 billion (down 110.51% YoY), while the FY2025 annual figure was -$4.0 billion, down 235.08% from the prior year.
- Notes Payables for Q2 2026 stood at -$5.8 billion, up from -$6.8 billion in the prior quarter.
- The five-year high for Notes Payables was $4.6 billion in Q4 2022, with the low at -$7.4 billion in Q2 2023.
- The 5-year median for Notes Payables is -$3.5 billion (2024), against an average of -$2.7 billion.
- The sharpest annual moves came in 2022 and 2023: Notes Payables jumped 93.37% in 2022, then plunged 1686.97% in 2023.
- Gsk's Notes Payables stood at $4.6 billion in 2022, then dropped by 25.03% to $3.5 billion in 2023, then declined by 15.05% to $3.0 billion in 2024, then slumped by 112.39% to -$365.8 million in 2025, then sank by 1473.87% to -$5.8 billion in 2026.
- Business Quant data shows GSK's Notes Payables at -$5.8 billion in Q2 2026, -$6.8 billion in Q1 2026, and -$365.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.76 Bn |
| Mar 31, 2026 | -6.80 Bn |
| Dec 31, 2025 | -365.80 Mn |
| Sep 30, 2025 | -3.85 Bn |
| Jun 30, 2025 | -2.73 Bn |
| Mar 31, 2025 | -2.47 Bn |
| Dec 31, 2024 | 2.95 Bn |
| Sep 30, 2024 | -3.66 Bn |
| Jun 30, 2024 | -4.25 Bn |
| Mar 31, 2024 | -3.32 Bn |
| Dec 31, 2023 | 3.48 Bn |
| Sep 30, 2023 | -6.13 Bn |
| Jun 30, 2023 | -7.41 Bn |
| Mar 31, 2023 | -5.18 Bn |
| Dec 31, 2022 | 4.64 Bn |
| Sep 30, 2022 | -3.29 Bn |
| Jun 30, 2022 | -4.19 Bn |
| Mar 31, 2022 | -289.84 Mn |
| Dec 31, 2021 | 4.85 Bn |
| Sep 30, 2021 | -6.71 Bn |